New Iscador® Prescribing Recommendations
  

<< back

By: Unknown Author
This article is posted with permission from Weleda USA's News for Health Professionals

Weleda-AG's new Iscador Recommendations outlined in attached Therapy chart (see below) are based primarily on the results of 4 retrospective epidemiological cohort studies on breast cancer, malignant melanoma, colorectal carcinoma and pancreatic carcinoma. These studies have been conducted in Europe by the IFAG Institute according to the criteria of good epidemiological practice (GEP). Their results reveal the following trends:
 
  • Breast cancer: a slight advantage of choosing Iscador P over Iscador M during peri and/or postmenopausal stages. Further findings from a prospective randomised clinical trial started in autumn of 2009 with Iscador M (currently suggested for pre-menopausal patients), will be communicated when available.
  • Malignant melanoma: a confirmation of Iscador P as the choice of host tree  
  • Colorectal carcinoma: a significant advantage of Iscador Qu, vs. Iscador M, in female and male patients (no gender specific differences were found).
  • Pancreatic carcinoma: a significant advantage of Iscador Qu, vs. Iscador M, in female and male patients (no gender specific differences were found).
 
The host tree recommendations for specific tumors which have not been researched in the above studies have been adjusted according to the considerable clinical experience of the Lukas clinic and the Association for Cancer Research in Switzerland.

IMPORTANT NOTE: If a patient responds well to his/her "old" therapy (local reaction around the injection site up to 2" in diameter, restoration of a circadian rhythm, etc.), there is no need to change the treatment. If it is changed nevertheless, or if the patient did not show an optimal reaction with the "old" therapy, one should start with Series 0 of the Iscador preparation recommended in the attached table and continue as indicated.

Therapy+Chart_2011.pdf




<< back

Dynamic Content Management by ContentTrakker